Today: 25 October 2025
Subscribe
AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?
 ·  ·  ·  ·  · 

AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

by
24 October 2025
  • AI Partnerships Drive AMD Rally: AMD recently inked blockbuster AI deals – a multi-year pact to supply OpenAI with GPUs powering 6 gigawatts of compute, and an Oracle Cloud agreement to deploy 50,000 of AMD’s next-generation Instinct GPUs [1] [2]. These contracts are projected to generate “tens of billions” in annual revenue and over $100 billion cumulatively in new sales [3] [4]. The news sparked a massive market reaction: on Oct. 6 AMD shares surged 34% in one day (the biggest gain since 2016) [5], adding roughly $80 billion to its market value.
  • Record Stock Performance: AMD stock has climbed roughly 80–95% year-to-date (as of late Oct. 2025), far outpacing peers [6] [7]. It briefly hit all-time highs in mid-October (around $238 per share [8]) before settling near ~$235 by Oct. 23 [9] [10]. For comparison, Intel shares trade near $38 (up ~85% YTD) [11] and NVIDIA (still dominant in AI GPUs) around $180. AMD’s ~$380 billion market cap now rivals Intel’s and sits behind only Nvidia (now a ~$4T company) [12]. Market observers note this rally is “extraordinary” – the Philadelphia Semiconductor Index is up only ~32% in 2025, so AMD’s gain stands out among chipmakers [13] [14].
  • Bullish Analyst Sentiment: Wall Street has grown very optimistic. Major firms have raised price targets into the mid-$200s to $300 range [15]. For example, Bank of America’s Vivek Arya hiked his 12-month target to $300 [16], Jefferies and Wolfe Research each raised targets to $300, and HSBC’s is $310 [17]. Overall about 60–65% of analysts rate AMD a “Buy,” compared to ~50% earlier in the year [18] [19]. Morgan Stanley recently bumped its 2027 revenue forecast to $51.2 billion (from $44.2B) on an improving datacenter outlook [20]. Even traditionally cautious houses (Goldman, Citigroup) have turned neutral-on-AMD after the AI agreements, while more bullish ones (Wedbush, Stifel) boosted targets – Wedbush raised its price target to $270 citing the AI deal thesis [21].
  • Strong Financial Results & Guidance: AMD’s latest earnings exceeded expectations. Q2 2025 revenue was $7.69 billion (up +32% YoY) and adjusted EPS $0.48 [22]. CEO Lisa Su noted product rollouts have contributed to the gain. The company guided Q3 2025 revenue to about $8.7 billion (up ~20% YoY) [23], with full-year 2025 sales now targeted near $33 billion [24]. CFO Jean Hu said the OpenAI agreement “should deliver tens of billions of dollars in revenue” and be “highly accretive” to future earnings [25]. Despite strong demand, growth is partly limited by U.S. export curbs: AMD expects a ~$1.5 billion hit to 2025 sales from restrictions on AI chip shipments to China [26].
  • Intel and NVIDIA Context: AMD’s rise comes against fierce competition. Nvidia remains the undisputed AI leader, commanding roughly 90–94% of the data-center GPU market [27]. In Nvidia’s last quarter, its data-center revenue jumped 73% to $39.1 billion [28], dwarfing AMD’s $3.2B (14% growth) for the same period. Nvidia’s CEO Jensen Huang has reacted to the AMD-OpenAI deal as “imaginative” and “surprising,” quipping that giving up 10% of AMD (through the OpenAI warrant) was “clever, I guess” [29]. Huang nonetheless praised AMD as “a really good company” that Nvidia takes “very seriously” [30], implying Nvidia will closely watch AMD’s execution. Intel is also ramping up AI: in mid-October it unveiled a new “Crescent Island” data-center AI chip for 2026 [31] [32] and secured major funding (the U.S. government’s CHIPS stake plus $7B from Nvidia/SoftBank) to boost its data-center focus [33]. In this context, AMD is pitching its GPUs, EPYC CPUs and new Helios AI server racks as an “open” alternative to Nvidia’s proprietary systems [34] [35].
  • Valuation & Risks: AMD’s rally has stretched valuations. TS2.Tech notes AMD now trades around 40× expected 2026 earnings (its trailing P/E exceeds 100×) [36] – rich even against Nvidia (~30×) [37]. Simply Wall St analysts flag that much of the growth is already baked in: they warn of “downside risk if growth projections prove too bullish or competition and regulatory challenges weigh on performance” [38]. In other words, at current price levels AMD’s multiples leave “little room for error” if orders disappoint or new products underperform [39] [40]. A few firms (Goldman Sachs, Citi) maintain neutral ratings with 12-mo targets near $210 [41] [42], citing high expectations. The stock’s elevated valuation means any broader tech selloff or stumble in AI demand could trigger profit-taking.
  • Outlook & Forecasts: Looking ahead, analysts paint both bullish and cautious scenarios. In the short term, AMD’s momentum may test up against market volatility – it must sustain high growth (and meet Nov. 4 Q3 results) to justify today’s levels [43] [44]. Bank of America, for example, forecasts AMD on a “conservative path to $10+” annual EPS by 2027 based on these AI ramps [45] – which would imply a three- to four-fold share-price gain. Wedbush’s thesis is that each gigawatt of AI capacity could mean roughly $20 billion in AMD sales [46]. If AMD can achieve production of the MI450/MI400X GPUs and ramp deals with hyperscalers (OpenAI, Oracle, Meta, etc.), many analysts believe its long-term growth will be substantial. Short-term, targets range mostly in the $240–$300 area [47] [48]. However, bears point out that if AMD fails to significantly dent NVIDIA’s AI dominance or if macro/regulatory headwinds emerge, the stock could retreat toward the $180–$210 range cited by some fair-value models [49] [50].

In summary, AMD’s recent AI-driven surge has been fueled by heavyweight partnerships and robust demand, earning plaudits from executives and analysts alike. But the stock now sits at lofty valuations. Investors will be watching closely whether AMD can translate its new AI wins into sustained growth – success could justify prices well above today’s $235, while any misstep might curb the rally. As one analyst quipped, AMD is striving to be the “open, secure, and scalable” AI platform versus Nvidia’s closed box [51]. Whether Wall Street’s bullish forecasts come true will depend on that bet paying off in the years ahead.

Sources: News and analyses from Reuters [52] [53], TS2.Tech [54] [55], CNBC/Benzinga [56], Fox Business [57], Investing.com [58], and Simply Wall St [59]. All data as of Oct. 24, 2025.

GET IN EARLY! I'm Buying This AI Chip Stock (Even Over NVIDIA Stock)
Watch this video on YouTube.

References

1. www.reuters.com, 2. www.reuters.com, 3. www.reuters.com, 4. ts2.tech, 5. www.reuters.com, 6. ts2.tech, 7. www.benzinga.com, 8. ts2.tech, 9. ts2.tech, 10. ts2.tech, 11. ts2.tech, 12. ts2.tech, 13. ts2.tech, 14. ts2.tech, 15. ts2.tech, 16. ts2.tech, 17. ts2.tech, 18. ts2.tech, 19. ts2.tech, 20. www.investing.com, 21. ts2.tech, 22. www.reuters.com, 23. ts2.tech, 24. ts2.tech, 25. ts2.tech, 26. www.reuters.com, 27. ts2.tech, 28. www.reuters.com, 29. www.benzinga.com, 30. www.benzinga.com, 31. ts2.tech, 32. ts2.tech, 33. ts2.tech, 34. ts2.tech, 35. www.reuters.com, 36. ts2.tech, 37. ts2.tech, 38. simplywall.st, 39. ts2.tech, 40. simplywall.st, 41. ts2.tech, 42. ts2.tech, 43. ts2.tech, 44. ts2.tech, 45. ts2.tech, 46. ts2.tech, 47. ts2.tech, 48. ts2.tech, 49. simplywall.st, 50. ts2.tech, 51. ts2.tech, 52. www.reuters.com, 53. www.reuters.com, 54. ts2.tech, 55. ts2.tech, 56. www.benzinga.com, 57. www.foxbusiness.com, 58. www.investing.com, 59. simplywall.st

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

  1. Comfort Systems (FIX) Stock Skyrockets 17% After Stellar Q3 — What’s Driving the Rally?
  2. Booz Allen (BAH) Stock Crashes 9% on Weak Q2; Outlook Cut, Analysts Split on Prospects
  3. MultiSensor AI Stock’s Wild Ride: +42% Rally on Major Deal, –50% Crash After $14M Funding
  4. Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal

Related Articles

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?
Previous Story

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside
Next Story

Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

Stock Market Today

  • Republic Services Stock Price Outlook 2025 and Beyond: Valuation, Targets, and Catalysts
    October 24, 2025, 12:18 PM EDT. Republic Services Inc (RSG) trades around $220, with a market cap near $69B. The stock shows a trailing P/E of 32.9 and a forward P/E of 28.9; year-to-date return ~ 10% in 2025, after an all-time high near $257. The company remains the No. 2 waste management player in North America, with 2025 earnings guidance of $16.75B. Wall Street looks constructive: a consensus Buy with a price target around $242; big banks like UBS, JPMorgan, and Oppenheimer imply upside toward the mid-$250s. Growth drivers include renewable natural gas, polymer centers, and recycling initiatives. Risks include valuation concerns in a competitive sector. Potential upside to 2030 remains a theme, supported by steady demand and sustainability investments.
  • Market Wrap: CPI Cooling to 3% Boosts Fed Cut Bets and Major Indices Rally
    October 24, 2025, 12:20 PM EDT. Live markets rally after inflation prints cooler than expected: CPI at 3%, below the 3.1% estimate for September. Core CPI rose 0.2% m/m and 3% y/y vs estimates of 0.3% and 3.1%. The data bolster bets on additional Fed rate cuts this year. The Dow Jones is higher by about 400 points, the S&P 500 up around 55, and the Nasdaq gaining roughly 235 as earnings help fuel momentum. In the session, Intel (INTC) posted Q3 sales of $13.65B, above $13.14B expectations, with net income of $4.1B (90 cents per share), reversing a year-ago loss. Traders will parse more results and guidance as earnings season continues.
  • IBB Biotechnology ETF Sees ~$139M Outflow; 1.4% WoW Decline
    October 24, 2025, 12:24 PM EDT. Week-over-week, the iShares Biotechnology ETF (IBB) posted about a $139.2 million outflow, a 1.4% drop in shares outstanding (65.9M to 65.0M). The ETF's 52-week range spans $142.465 to $177.37, with a last trade near $153.43. A comparison to the 200-day moving average is highlighted in the chart commentary. The fund's outflow signals redemption pressure that can affect its underlying holdings as units are destroyed. ETFs trade like stocks but create/destroy units to meet demand, so sizeable flows matter for liquidity and component weights. The piece also notes a link to other ETFs with notable outflows.
  • EFV Faces Big Outflow as $319 Million Leaves iShares MSCI EAFE Value ETF
    October 24, 2025, 12:28 PM EDT. ETF Channel data shows the iShares MSCI EAFE Value ETF (EFV) posting a notable week-over-week outflow of about $319.3 million, a 2.0% decline in shares outstanding (from 333.6M to 326.8M). Large holdings like CCEP, TEVA, and AER added modest gains today (+~0.5% to +0.7%) while investors moved cash out of EFV. The ETF's recent price sits near $47.34, within a 52-week range of $38.082-$51.235 and south of its recent 200-day moving average. The dynamic of creations and destructions in ETF units means underlying components may experience flow-driven price effects. For full holdings and more context, see EFV Holdings.
  • GOOG Stock To $230? Valuation Flags Pullback Risk Amid Strong Fundamentals
    October 24, 2025, 12:30 PM EDT. GOOG has surged ~57% since April, trading above $250, but Trefis flags a Very High valuation. While Alphabet's fundamentals remain strong-revenue growth clustered around mid-teens, robust profitability (operating margin ~32.7%), and solid cash flow-the stock appears expensive relative to the market. The model suggests a potential pullback toward $230, offering a possible entry point but with limited fundamental risk. The piece highlights Alphabet's diverse business lines (ads, Android, YouTube, cloud) and asserts the value of a high-quality portfolio approach rather than a single-name bet. Investors should weigh valuation against continued growth prospects and financial stability, and consider whether the stock's upside justifies the current premium.
Go toTop